Effectiveness and Safety of Intradetrusor OnabotulinumtoxinA Injection for Neurogenic Detrusor Overactivity and Overactive Bladder Patients in Taiwan-A Phase IV Prospective, Interventional, Multiple-Center Study (Restore Study). [PDF]
Wang CC +7 more
europepmc +1 more source
A Novel Approach to Botulinum Toxin Injection for Neurogenic Detrusor Overactivity in Children. [PDF]
Marte A.
europepmc +1 more source
Development of Neurogenic Detrusor Overactivity after Thoracic Spinal Cord Injury Is Accompanied by Time-Dependent Changes in Lumbosacral Expression of Axonal Growth Regulators. [PDF]
Chambel SS +7 more
europepmc +1 more source
Effect of Bladder Injections of Botulinum Neurotoxin A on Biomarkers Associated with Inflammation and Urinary Infections in Patients with Neurogenic Detrusor Overactivity-Associated Incontinence: A Pilot, Prospective, Human Study. [PDF]
Gatsos S +8 more
europepmc +1 more source
Effectiveness of transcutaneous tibial nerve stimulation on anticholinergic refractory neurogenic detrusor overactivity in individuals with suprasacral spinal cord injury: A urodynamic study. [PDF]
Ozisler Z, Sipal MS, Yildirim S.
europepmc +1 more source
Urodynamic efficacy of fesoterodine for the treatment of neurogenic detrusor overactivity and/or low compliance bladder. [PDF]
Kaga K +5 more
europepmc +1 more source
Editorial Comment: Long-term outcomes and risks factors for failure of intradetrusor onabotulinumtoxin A injections for the treatment of refractory neurogenic detrusor overactivity. [PDF]
Averbeck MA.
europepmc +1 more source
Dorsal Genital Nerve Stimulation as an Adjunctive Therapy to Control Neurogenic Detrusor Overactivity After Spinal Cord Injury. [PDF]
Doherty S +4 more
europepmc +1 more source
Effect of Oxybutynin on Detrusor Leak Point Pressure in Spinal Cord Injury Patients With Neurogenic Detrusor Overactivity: A Subgroup Analysis. [PDF]
Bharti V, Joshi M, Saini N.
europepmc +1 more source
The intravesical injection of highly purified botulinum toxin for the treatment of neurogenic detrusor overactivity. [PDF]
Asafu-Adjei D +5 more
europepmc +1 more source

